Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile
Wafik S. El-Deiry, MD, PhD, FACP

@weldeiry

Physician-Scientist Med Onc Pubs tinyurl.com/s98xg3u Director @BrownUCancer Associate Dean @BrownMedicine @americancancer Prof Entrepreneur Boat Captain

ID: 14562968

linkhttps://www.linkedin.com/in/wafike/ calendar_today27-04-2008 23:44:29

58,58K Tweet

15,15K Followers

10,10K Following

Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactions “study underscores the inter-patient diversity of tumour-induced systemic changes and emphasizes the need for treatments tailored to different B and myeloid cell abnormalities”

Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

The Partnership to Reduce Cancer in Rhode Island is holding the 2024 Annual Cancer Summit featuring keynote presentation by Dr. Sheldon Holder, Associate Director for Diversity, Equity, and Inclusion at the Legorreta Cancer Center of Brown University speaking about ‘Cancer:

The Partnership to Reduce Cancer in Rhode Island is holding the 2024 Annual Cancer Summit featuring keynote presentation by Dr. Sheldon Holder, Associate Director for Diversity, Equity, and Inclusion at the Legorreta Cancer Center of Brown University speaking about ‘Cancer:
Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Point of View: Applied research won’t flourish without basic science Jon R Lorsch, Lawrence A Tabak, and Monica M Bertagnolli elifesciences.org/articles/102368

Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Happy Friday, Osler tie day. Here are some words from experience: Academic medicine, especially for physician-scientists is a very exciting and challenging career that I have had the privilege of being part of for three decades. Persistence, and perhaps resilience as more

Happy Friday, Osler tie day. 

Here are some words from experience:

Academic medicine, especially for physician-scientists is a very exciting and challenging career that I have had the privilege of being part of for three decades. Persistence, and perhaps resilience as more
Vida Tajiknia M.D. (@tajiknia) 's Twitter Profile Photo

"Check it out! Just got my ECFMG certification in the mail. 🙌 Opened it at my lab bench for good luck, 'cause that 'bench to bedside' dream is alive and kicking. Here's to getting matched and helping to end cancer deaths! #ECFMG #IMG #Residency #Match2025 Huge thanks to my

"Check it out! Just got my ECFMG certification in the mail. 🙌 Opened it at my lab bench for good luck, 'cause that 'bench to bedside' dream is alive and kicking. Here's to getting matched and helping to end cancer deaths! #ECFMG #IMG #Residency #Match2025 
Huge thanks to my
Karen Knudsen, MBA PhD (@amercancerceo) 's Twitter Profile Photo

Leading the American Cancer Society Society + American Cancer Society Cancer Action Network is the honor of a lifetime. Over the last 3.5 years, we increased our impact and focused on improving the lives of cancer patients. I love this org! With ACS on strong footing and having accomplished what I came to achieve, today I

Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

CEO of the American Cancer Society Announces Transition Plans Transformative leader will enter the next phase of her strategy to accelerate progress against cancer pressroom.cancer.org/releases?item=…

Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Another fantastic talk by Professor Jeff Rosen at Dan L Duncan Comprehensive Cancer Center at the 2nd annual translational oncology symposium organized by Sendurai Mani Dr. Rosen spoke about translational mouse model research on TNBC where immune checkpoint blockade is not particularly effective in

Another fantastic talk by Professor Jeff Rosen at <a href="/BCMCancerCenter/">Dan L Duncan Comprehensive Cancer Center</a> at the 2nd annual translational oncology symposium organized by <a href="/SenduraiMani/">Sendurai Mani</a> 

Dr. Rosen spoke about translational mouse model research on TNBC where immune checkpoint blockade is not particularly effective in
Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Dr. Matt Meyerson Dana-Farber speaks at 2nd annual translational oncology symposium organized by Sendurai Mani at #LegorretaCancerCenter Legorreta Cancer Center at Brown University The Warren Alpert Medical School. He discussed progress in lung cancer since 1998 when he started his lab to the present. In 1998 it cost $3B to

Dr. Matt Meyerson <a href="/DanaFarber/">Dana-Farber</a> speaks at 2nd annual translational oncology symposium organized by <a href="/SenduraiMani/">Sendurai Mani</a> at #LegorretaCancerCenter <a href="/BrownUCancer/">Legorreta Cancer Center at Brown University</a> <a href="/BrownMedicine/">The Warren Alpert Medical School</a>. He discussed progress in lung cancer since 1998 when he started his lab to the present. In 1998 it cost $3B to